Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSENS.L Share News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Cake Box trading strong; Sensyne falls further

Tue, 19th Apr 2022 11:06

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

----------

AIM - WINNERS

----------

Cake Box Holdings PLC, up 11% at 214.00 pence, 12-month range 135.00p-428.00p. The fresh cream cakes retailer said trading across second half ended March 31 was strong and, as a result, expects annual revenue to be up 50%, with adjusted pretax profit in line with market forecasts. "There continues to be a high level of interest in Cake Box's differentiated franchise proposition, with both strong demand for new stores from existing franchisees and a pipeline of new franchisee applicants representing 53 holding deposits held at the period end," it says.

----------

Empyrean Energy PLC, up 9.6% at 11.18p, 12-month range 4.90p-13.00p. Says LH 17-2-1 well at the Jade prospect offshore China drilled 12-1/4" section to 2,150 metres measured depth and results have validated the pre-drill interpretation of seismic data including the presence of gas clouds over the Jade as well as Topaz prospects. "Based on the results thus far, Empyrean has upgraded its internal geological chance of success over the Jade prospect from 41% to 65% and Topaz prospect from 35% to 47%," it says.

----------

AIM - LOSERS

----------

Sensyne Health PLC, down 32% at 1.24p, 12-month range 1.00p-178.00p. Decides to end formal sale process in light of amended financing agreement and will seek approval to delist from AIM. The amendment provides access to up to GBP20 million in additional capital. "Without access to the additional capital provided by the noteholders pursuant to the amended and restated note purchase agreement, the company is unlikely to be able to continue to trade and would very likely become insolvent and be placed into administration," Sensyne warns. Stock down 98% in year-to-date.

----------

Serabi Gold PLC, down 14% at 50.88p, 12-month range 46.00p-80.00p. The Brazil-focused gold miner says production has taken a hit during the first quarter, consequently lowering its full-year production guidance. Gold production in the first quarter at Palito was 7,062 ounces, down 13% year-on-year from 8,087 ounces. Serabi lowers production guidance for 2022 to 30,000 ounces, down from a previous range of between 36,000 and 39,000 ounces.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
7 May 2021 19:23

IN BRIEF: Sensyne Health gets UK heath regulator boost

IN BRIEF: Sensyne Health gets UK heath regulator boost

Read more
7 May 2021 08:55

Sensyne's 'MagnifEye' gets MHRA special use authorisation

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health announced on Friday that its 'MagnifEye' software application, which uses AI to automate the accurate reading and analysis of lateral flow diagnostic tests, has been granted special use authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA).

Read more
30 Apr 2021 14:45

Sensyne Health signs research deal with another NHS trust

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has signed a five-year non-exclusive strategic research agreement (SRA) with the Royal Devon and Exeter NHS Foundation Trust, it announced on Friday.

Read more
30 Apr 2021 14:15

TRADING UPDATES: Henry Boot gets planning boost; Beximco sales jump

TRADING UPDATES: Henry Boot gets planning boost; Beximco sales jump

Read more
12 Mar 2021 13:03

IN BRIEF: Sensyne signs deal with UK government to fund Covid tests

IN BRIEF: Sensyne signs deal with UK government to fund Covid tests

Read more
12 Mar 2021 09:23

Sensyne signs £0.5m Covid-19 test deal with DHSC

(Sharecast News) - Clinical artificial intelligence (AI) technology company Sensyne Health has signed a £0.47m agreement with the Department of Health and Social Care, it announced on Friday, to conduct the second stage of a pilot study of its 'MagnifEye' technology for use with Covid-19 lateral flow diagnostic tests.

Read more
1 Mar 2021 16:41

EXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma

EXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma

Read more
1 Mar 2021 15:36

Sensyne Health gets UK approval for 'SYNE-COV' algorithm

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health announced on Monday that its 'SYNE-COV' machine learning algorithm for Covid-19 risk prediction has achieved regulatory approval for use in the UK.

Read more
1 Mar 2021 15:34

TRADING UPDATES: 1Spatial expects full-year results ahead of forecasts

TRADING UPDATES: 1Spatial expects full-year results ahead of forecasts

Read more
9 Feb 2021 14:43

Sensyne Health signs licence agreement with Excalibur

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has signed an exclusive licence and development agreement with Excalibur Healthcare Services, it announced on Tuesday, to apply Sensyne's 'MagnifEye' system for use with Excalibur's proprietary lateral flow rapid diagnostic tests across a range of indications, including its Covid-19 antigen test currently being marketed in the UK and Europe.

Read more
9 Feb 2021 11:18

TRADING UPDATES: Northbridge, discoverIE And Tandem Outlook Upbeat

TRADING UPDATES: Northbridge, discoverIE And Tandem Outlook Upbeat

Read more
5 Feb 2021 12:28

EXECUTIVE CHANGES: Iconic Labs CEO; Tiziana Hires Executive Director

EXECUTIVE CHANGES: Iconic Labs CEO; Tiziana Hires Executive Director

Read more
3 Feb 2021 11:07

IN BRIEF: Sensyne Health Launches AI Algorithm For Patient Management

IN BRIEF: Sensyne Health Launches AI Algorithm For Patient Management

Read more
21 Jan 2021 11:32

Sensyne Health Interim Loss Widens But Boasts Of Commercial Progress

Sensyne Health Interim Loss Widens But Boasts Of Commercial Progress

Read more
20 Jan 2021 19:18

IN BRIEF: Sensyne Health Signs Long-Term Deal With NHS Trust

IN BRIEF: Sensyne Health Signs Long-Term Deal With NHS Trust

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.